RECEPTOR-TYPE TYROSINE-PROTEIN KINASE FLT3

Approval Year

Substance Class	Protein Created by `admin` on `Sat Dec 16 12:34:33 GMT 2023` Edited by `admin` on `Sat Dec 16 12:34:33 GMT 2023`
Protein Type	RECEPTOR
Protein Sub Type	TYROSINE KINASE
Sequence Origin	HUMAN
Sequence Type	COMPLETE
Record UNII	4796L35A70
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

RECEPTOR-TYPE TYROSINE-PROTEIN KINASE FLT3

Common Name

English

FLT3

Common Name

English

CD135

Common Name

English

FETAL LIVER KINASE-2

Common Name

English

FMS-LIKE TYROSINE KINASE 3

Common Name

English

FLK2

Common Name

English

FL CYTOKINE RECEPTOR

Common Name

English

FLT-3

Common Name

English

STEM CELL TYROSINE KINASE 1

Common Name

English

Code System Code Type Description

PHAROS

P36888

Created by admin on Sat Dec 16 12:34:34 GMT 2023 , Edited by admin on Sat Dec 16 12:34:34 GMT 2023

PRIMARY

FDA UNII

4796L35A70

Created by admin on Sat Dec 16 12:34:34 GMT 2023 , Edited by admin on Sat Dec 16 12:34:34 GMT 2023

PRIMARY

UNIPROT

P36888

Created by admin on Sat Dec 16 12:34:34 GMT 2023 , Edited by admin on Sat Dec 16 12:34:34 GMT 2023

PRIMARY

From	To
1_9	1_39
1_77	1_88
1_173	1_180
1_206	1_215
1_246	1_304
1_342	1_381
1_355	1_366

Glycosylation Type

HUMAN

Glycosylation Link Type	Site
N	1_17
N	1_74
N	1_125
N	1_280
N	1_297
N	1_325
N	1_328
N	1_447
N	1_476
N	1_515

Related Record Type Details


					6L5D03D975

ILORASERTIB

INHIBITOR -> TARGET

Amount:


					I136775ABW

PF-06273340

INHIBITOR->OFF-TARGET

Amount:


					8QR88H79VX

MIVAVOTINIB

INHIBITOR -> TARGET


					G22N65IL3O

PACRITINIB

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					6MC966B505

FN-1501

INHIBITOR -> TARGET


					2D9N67F58G

KW-2449

INHIBITOR -> TARGET


					DO989GC5D1

LESTAURTINIB

INHIBITOR -> TARGET

Amount:


					6L1XP550I6

FEDRATINIB

INHIBITOR -> TARGET


					AQ3TTU8UM7

Ruserontinib

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					2MT30EHI63

MRX-2843

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					CDI2Y58ICE

BPR-1K871

INHIBITOR -> TARGET


					66D92MGC8M

GILTERITINIB

INHIBITOR -> TARGET


					ID912S5VON

MIDOSTAURIN

INHIBITOR -> TARGET

Amount:


					C0WUS7XXE9

Tuspetinib

INHIBITOR -> TARGET

Comments:

ALSO ACTIVE AGAINST FLT3 ITD and FLT3 D835Y kinases were 1.8 nM and 1.0 nM

Amount:


					V99T50803M

SUNITINIB

INHIBITOR -> TARGET


					U2UY9TBQ8Z

PHI-101

INHIBITOR -> TARGET


					D9B1PJ9MWX

CGP-52421

INHIBITOR -> TARGET


					J8AY0Z4CBP

CEP-11981

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					9M7X64VTLI

SEL-24

INHIBITOR -> TARGET

Qualification:

Kd

Amount:


					PW3Q92Z6A4

NINGETINIB

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					P9I9Z3MF7Z

Emirodatamab

LIGAND->TARGET

Amount:


					YKQ241VJ92

JNJ-28312141 FREE BASE

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					SAY8KVM4HU

BMS-794833

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					6783M2LV5X

PEXIDARTINIB

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					E1IO3ICJ9A

TANDUTINIB

INHIBITOR -> TARGET

Amount:


					TQ6PBX1JU0

LUXEPTINIB

INHIBITOR -> TARGET

Comments:

ALSO ACTIVE AGAINST FLT3-ITD mutants

Qualification:

IC50

Amount:


					ZE94SP78UG

EP-0042

INHIBITOR -> TARGET

Amount:


					H3W3QJ5C7G

CGP-62221

INHIBITOR -> TARGET


					9FJ3MBL7XW

TSN-084

INHIBITOR -> TARGET

Interaction Type:

PRECLINICAL

Amount:


					5277GPA358

CENISERTIB

INHIBITOR -> TARGET

Interaction Type:

COMPETITIVE INHIBITOR

Qualification:

IC50

Amount:


					DL772G3NN7

MAX-40279

INHIBITOR -> TARGET


					9ZOQ3TZI87

SORAFENIB

INHIBITOR -> TARGET


					Y6UHU32G5Z

IDRX-42

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					B06W426B66

DENFIVONTINIB

INHIBITOR -> TARGET

Qualification:

IC50

Amount:

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT	CHEMICAL
Molecular Formula	CHEMICAL